VX-809 25mg
VX-809 is the second investigational oral candidate compound for the treatment of cystic fibrosis (CF).
| Trivial name | VX-809 25mg |
| Catalog Number | A10986-25 |
| Alternative Name(s) | 3-{6-{[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropanecarbonyl]amino}-3-methylpyridin-2-yl}benzoic acid |
| Molecular Formula | C24H18F2N2O5 |
| CAS# | 936727-05-8 |
| SMILES | CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O |
| Size | 25mg |
| Supplier Page | http://www.adooq.com/vx-809.html |